3rd Quarter 2019 Wrap Up – Equity Overview & Rambus Chartology
“Nominal GDP growth over the past five years would have been negative if U.S. public debt had not increased, one thing everybody seems to miss when they look at these GDP numbers … they seem to not understand that the growth in the GDP it looks pretty good on the screen is really based exclusively on debt—government debt, also corporate debt and even now some growth in mortgage debt.”
~ Jeffrey Gundlach
By Catherine Austin Fitts
This week is the 3rd Quarter 2019 Equity Overview with the quarterly blockbuster from Rambus Chartology. Check out the web presentation here for the quarterly financial charts and Rambus Chartology when posted on Thursday.
The U.S. equity market continues to outperform global equity markets.
The Trump administration considers the U.S. stock market an essential performance indicator. The administration’s target appears to be a Dow above 30,000. Last quarter, I discussed what this means in terms of practical policies—from FASAB 56, to privatization and federal deregulation, to lower Fed interest rates that permit government and large corporations to carry high debt levels at a lower cost of capital.
Also discussed were trends that could pinch corporate profits, including increased chances of recession, explosive U.S. sovereign debt, the decline of the unipolar model, and the challenges of the U.S.-China trade war and changing global supply lines. And, oh yes, the effort to start World War III.
This quarter, I will focus on the storm clouds gathering for the large cap U.S. tech and health care companies that have contributed to the outperformance of U.S. stocks. The tech giants are the target of serious antitrust investigations by federal and state agencies. The global efforts to tax multinationals will increasingly limit jurisdictional flexibility. Large jury awards related to opioids and pesticides also indicate a growing willingness to enforce expensive accountability against irresponsible corporate behavior.
Is the ability of the U.S. political class to engineer outsized monopoly profits into its largest corporations coming to an end? Or, in the face of rising backlash against political corruption and inequality, are we simply witnessing a shift to secret revenues and assets engineered through the Fed, Treasury, and mortgage markets? I will also address the mother lode of all financial steroids—Secretary Mnuchin’s proposal for privatizing mortgage giants Fannie Mae and Freddie Mac—and its implications in combination with FASAB 56 and national security law.
Please e-mail your questions for Ask Catherine or post them at the Money & Markets commentary here.
Talk to you Thursday!
See post here.
|
Upcoming Reports:
October 24, 2019 - Future Science Series with Ulrike Granögger
October 31, 2019 - Leonardo da Vinci & the Power of Our Imagination with Jon Rappoport
November 7, 2019 - Secrecy Grows with Amy Benjamin
From the Site:
Catherine’s Money & Markets Report: October 17, 2019
Book Review: The Autism Vaccine
Best of Precious Metals Market Report: Franklin Sanders on How to Buy & Store Silver & Gold – Part IV
Hero of the Week: October 17, 2019 – Dietrich Klinghardt, MD, PhD
Let’s Go to the Movies: October 17, 2019 – In Search of Greatness
Blast from the Past
Join Catherine and Help Attorney Alan Phillips
The Solari Report Twitter Feed
|
